Munich - Delayed Quote • EUR
Elixinol Wellness Ltd (E8M.MU)
At close: May 31 at 8:15 AM GMT+2
Loading Chart for E8M.MU
DELL
- Previous Close
0.0010 - Open
0.0010 - Bid 0.0005 x --
- Ask 0.0055 x --
- Day's Range
0.0010 - 0.0010 - 52 Week Range
0.0010 - 0.0090 - Volume
2,479 - Avg. Volume
1,352 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 28, 2024 - Sep 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: E8M.MU
Performance Overview: E8M.MU
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
E8M.MU
81.82%
S&P/ASX 200 [XJO]
1.46%
1-Year Return
E8M.MU
88.89%
S&P/ASX 200 [XJO]
8.61%
3-Year Return
E8M.MU
99.10%
S&P/ASX 200 [XJO]
7.54%
5-Year Return
E8M.MU
99.96%
S&P/ASX 200 [XJO]
20.40%
Compare To: E8M.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.0010
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0320
+10.34%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0650
0.00%
Mkt Cap CAD 10.025M
Industry Drug Manufacturers—Specialty & Generic
0.0669
-0.30%
Mkt Cap 7.326M
Industry Drug Manufacturers—Specialty & Generic
0.0500
-28.57%
Mkt Cap 1.215M
Industry Drug Manufacturers—Specialty & Generic
3.7200
0.00%
Mkt Cap CAD 118.35M
Industry Drug Manufacturers—Specialty & Generic
1.6200
-0.61%
Mkt Cap CAD 39.622M
Industry Drug Manufacturers—Specialty & Generic
0.1300
+23.81%
Mkt Cap CAD 16.539M
Industry Drug Manufacturers—Specialty & Generic
0.4000
-4.76%
Mkt Cap CAD 16.841M
Industry Drug Manufacturers—Specialty & Generic
0.1300
0.00%
Mkt Cap CAD 20.929M
Industry Drug Manufacturers—Specialty & Generic
0.0700
-6.67%
Mkt Cap CAD 28.633M
Industry Drug Manufacturers—Specialty & Generic
Statistics: E8M.MU
Valuation Measures
As of 5/30/2024
Market Cap
3.98M
Enterprise Value
4.32M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.12
Price/Book (mrq)
0.33
Enterprise Value/Revenue
0.85
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--